Medications for Tuberculosis Intensive Phase (2 Months)
The intensive phase of drug-susceptible tuberculosis treatment consists of four medications: isoniazid, rifampin, pyrazinamide, and ethambutol, given daily for 2 months. 1, 2, 3
Standard Four-Drug Regimen
The intensive phase medications are:
- Isoniazid (H) - 5 mg/kg daily (300 mg for adults)
- Rifampin (R) - 10 mg/kg daily (450 mg if <50 kg; 600 mg if ≥50 kg)
- Pyrazinamide (Z) - 25 mg/kg daily (1.5 g if <50 kg; 2.0 g if ≥50 kg)
- Ethambutol (E) - 15 mg/kg daily
When Ethambutol Can Be Omitted
Ethambutol may be excluded from the intensive phase only if drug susceptibility testing confirms the organism is fully susceptible to isoniazid and rifampin, or in previously untreated patients at very low risk for drug resistance. 1, 3 This applies specifically to patients who are HIV-negative, have no known contact with drug-resistant TB, and are from populations with documented low rates (<2%) of isoniazid resistance. However, given the increasing prevalence of drug resistance globally, starting with all four drugs is the safer approach until susceptibility results are available. 1
Dosing Frequency Options
While daily dosing throughout the intensive phase is strongly recommended 2, alternative evidence-based schedules exist:
- Daily for 2 months (preferred) 1, 2
- Daily for 2 weeks, then twice weekly for 6 weeks 1
- Three times weekly throughout 1
Daily dosing is superior and should be the default choice, particularly for HIV-infected patients with CD4+ counts <100 cells/mm³, who should never receive once- or twice-weekly regimens during the intensive phase due to increased risk of rifampin resistance. 4
Fixed-Dose Combinations
Fixed-dose combination tablets containing 2,3, or 4 drugs are recommended as they improve adherence and prevent selective drug resistance. 2 These formulations have equivalent bioavailability and efficacy compared to separate drug administration. 5
Special Populations
For tuberculous meningitis or CNS tuberculosis, the same four-drug intensive phase is used for 2 months, but the total treatment duration extends to 12 months (not 6 months). 3, 6, 7 The intensive phase medications and doses remain identical.
For HIV co-infected patients, the same four-drug intensive phase applies, though timing of antiretroviral therapy initiation should be delayed 4-8 weeks after starting TB treatment to minimize drug interactions and paradoxical reactions. 4
Common Pitfall
Do not add a single drug to a failing regimen or use monotherapy at any point, as this rapidly selects for drug resistance. 4 If drug susceptibility results reveal resistance, the entire regimen must be redesigned with multiple effective agents, not simply supplemented with one additional drug.
Monitoring During Intensive Phase
Drug susceptibility testing should be performed on all initial isolates. 4 If cultures remain positive at 2 months, the intensive phase should be extended until susceptibility is confirmed, and the continuation phase may need to be prolonged to 7 months (total 9 months of treatment). 1, 4